The International Bladder Cancer Group (IBCG) is a globally recognized entity that has published numerous peer-reviewed articles addressing knowledge gaps in - and providing recommendations for - the management of bladder cancer.The IBCG was formed with a primary objective being to address global educational needs and learning gaps in order to improve the care and management of patients with urothelial carcinoma. The inaugural meeting, in 2006, consisted of members selected as representatives of their varied geographic regions across Europe, North America and Asia. The members were specifically selected not only for their expertise but also to ensure representation from across the globe.Over the years, the mission of the IBCG has been to improve outcomes of patients suffering from bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment. An additional goal is to develop practical educational tools that are applicable to the global uro
Reported officers (all unpaid)
No paid executives reported in 2024. International Bladder Cancer Group reported 3 unpaid officers and board members on its 990.
What Medical Research executives earn
International Bladder Cancer Group reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $120,264.
These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).
See full Medical Research compensation data →Common questions about International Bladder Cancer Group
What are International Bladder Cancer Group's revenue and expenses?
In 2024, International Bladder Cancer Group reported $392k in total revenue and $311k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.